Stocks and Investing
Stocks and Investing
Wed, November 8, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mike Matson Maintained (VCYT) at Strong Buy with Decreased Target to $30 on, Nov 8th, 2023
Mike Matson of Needham, Maintained "Veracyte, Inc." (VCYT) at Strong Buy with Decreased Target from $35 to $30 on, Nov 8th, 2023.
Mike has made no other calls on VCYT in the last 4 months.
There are 3 other peers that have a rating on VCYT. Out of the 3 peers that are also analyzing VCYT, 0 agree with Mike's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Mike
- Matthew Sykes of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $32 on, Monday, October 23rd, 2023
- Mason Carrico of "Stephens & Co." Reiterated at Buy and Held Target at $34 on, Tuesday, October 10th, 2023
- Tejas Savant of "Morgan Stanley" Maintained at Sell with Increased Target to $23 on, Wednesday, August 9th, 2023
Contributing Sources